This winter we’re seeing high rates of COVID and the re-emergence of influenza. So how do they compare, in terms of transmissibility and deadliness?
- Professor of Evidence-Based Practice, Institute for Evidence-Based Healthcare, Bond University
AstraZeneca, Pfizer and Moderna appear equivalent in reducing your chance of serious illness from COVID-19.
Contact David for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- ORCID
- Joined
